Misfolded superoxide dismutase-1 in CSF from amyotrophic lateral sclerosis patients

Journal of Neurochemistry

Volumn 117, Issue 1, 2011, Pages 91-99

  Zetterstöm, Per ^a   Andersen, Peter M ^a   Brännström, Thomas ^a   Marklund, Stefan L ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Amyotrophic lateral sclerosis; Biomarker; CSF; ELISA; Misfolding; Superoxide dismutase 1

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE;

AMINO ACID SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; INTERSTITIUM; MAJOR CLINICAL STUDY; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN MODIFICATION; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BIOLOGICAL MARKERS; HUMANS; MALE; MICE; MICE, TRANSGENIC; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN FOLDING; SUPEROXIDE DISMUTASE;

EID: 79952572373     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07177.x     Document Type: Article

References (36)

1. Andersen P. M., Nilsson P., Ala-Hurula V., Keranen M. L., Tarvainen I., Haltia T., Nilsson L., Binzer M., Forsgren L. and Marklund S. L. (1995) Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nat. Genet. 10, 61-66.
2. Andersen P. M., Borasio G. D., Dengler R., Hardiman O., Kollewe K., Leigh P. N., Pradat P. F., Silani V. and Tomik B. (2005) EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. Eur. J. Neurol. 12, 921-938.
3. Arisato T., Okubo R., Arata H. et al. (2003) Clinical and pathological studies of familial amyotrophic lateral sclerosis (FALS) with SOD1 H46R mutation in large Japanese families. Acta Neuropathol. 106, 561-568. (Pubitemid 37441613)
4. Arnesano F., Banci L., Bertini I., Martinelli M., Furukawa Y. and O'Halloran T. V. (2004) The unusually stable quaternary structure of human Cu,Zn-superoxide dismutase 1 is controlled by both metal occupancy and disulfide status. J. Biol. Chem. 279, 47998-48003.
5. Bosco D. A., Morfini G., Karabacak N. M. et al. (2010) Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat. Neurosci. 13, 1396-1403.
6. Bowling A. C., Schulz J. B., Brown Jr R. H. and Beal M. F. (1993) Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem. 61, 2322-2325. (Pubitemid 23354097)
7. Cashman N., Yanai A. and Grad L. (2009) Template-directed misfolding of SOD1 in vitro: A model for ALS propagation? 20th International Symposium on ALS/MND, Berlin, Germany. Amyotroph. Lateral Scler. 10(Suppl 11), 19.
8. Chia R., Tattum M. H., Jones S., Collinge J., Fisher E. M. and Jackson G. S. (2010) Superoxide dismutase 1 and tgSOD1 mouse spinal cord seed fibrils, suggesting a propagative cell death mechanism in amyotrophic lateral sclerosis. PLoS ONE 5, e10627.
9. Ezzi S. A., Urushitani M. and Julien J. P. (2007) Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation. J. Neurochem. 102, 170-178. (Pubitemid 46906269)
10. Forsberg K., Jonsson P. A., Andersen P. M., Bergemalm D., Graffmo K. S., Hultdin M., Jacobsson J., Rosquist R., Marklund S. L. and Brannstrom T. (2010) Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients. PLoS ONE 5, e11552.
11. Fukada K., Nagano S., Satoh M., Tohyama C., Nakanishi T., Shimizu A., Yanagihara T. and Sakoda S. (2001) Stabilization of mutant Cu/Zn superoxide dismutase (SOD1) protein by coexpressed wild SOD1 protein accelerates the disease progression in familial amyotrophic lateral sclerosis mice. Eur. J. Neurosci. 14, 2032-2036.
12. Gros-Louis F., Soucy G., Lariviere R. and Julien J. P. (2010) Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS. J. Neurochem. 113, 1188-1199.
13. Grosskreutz J., Kaufmann J., Fradrich J., Dengler R., Heinze H. J. and Peschel T. (2006) Widespread sensorimotor and frontal cortical atrophy in Amyotrophic Lateral Sclerosis. BMC Neurol. 6, 17.
14. Gurney M. E., Pu H., Chiu A. Y. et al. (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264, 1772-1775. (Pubitemid 24227760)
15. Ilieva H., Polymenidou M. and Cleveland D. W. (2009) Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell Biol. 187, 761-772.
16. Jaarsma D., Haasdijk E. D., Grashorn J. A. C., Hawkins R., van Duijn W., Verspaget H. W., London J. and Holstege J. C. (2000) Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1. Neurobiol. Dis. 7, 623-643.
17. Jacobsson J., Jonsson P. A., Andersen P. M., Forsgren L. and Marklund S. L. (2001) Superoxide dismutase in CSF from amyotrophic lateral sclerosis patients with and without CuZn-superoxide dismutase mutations. Brain 124, 1461-1466. (Pubitemid 32606106)
18. Jonsson P. A., Ernhill K., Andersen P. M., Bergemalm D., Brannstrom T., Gredal O., Nilsson P. and Marklund S. L. (2004) Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis. Brain 127, 73-88. (Pubitemid 38055347)
19. Jonsson P. A., Graffmo K. S., Andersen P. M., Brannstrom T., Lindberg M., Oliveberg M. and Marklund S. L. (2006) Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models. Brain 129, 451-464. (Pubitemid 43164368)
20. Jonsson P. A., Graffmo K. S., Andersen P. M., Marklund S. L. and Brannstrom T. (2009) Superoxide dismutase in amyotrophic lateral sclerosis patients homozygous for the D90A mutation. Neurobiol. Dis. 36, 421-424.
21. Kato S., Takikawa M., Nakashima K., Hirano A., Cleveland D. W., Kusaka H., Shibata N., Kato M., Nakano I. and Ohama E. (2000) New consensus research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 (SOD1) gene mutations: inclusions containing SOD1 in neurons and astrocytes. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 1, 163-184.
22. Lindberg M. J., Tibell L. and Oliveberg M. (2002) Common denominator of Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis: decreased stability of the apo state. Proc. Natl Acad. Sci. USA 99, 16607-16612.
23. Marklund S. L., Andersen P. M., Forsgren L., Nilsson P., Ohlsson P. I., Wikander G. and Oberg A. (1997) Normal binding and reactivity of copper in mutant superoxide dismutase isolated from amyotrophic lateral sclerosis patients. J. Neurochem. 69, 675-681. (Pubitemid 27327970)
24. Milhorat T. H. (1987) Physiology of the cerebrospinal fluid, in Cerebrospinal Fluid and the Brain Edemas (Milhorat T. H., ed.), pp. 39-73. Neuroscience Society of New York, New York.
25. Mondola P., Annella T., Santillo M. and Santangelo F. (1996) Evidence for secretion of cytosolic CuZn superoxide dismutase by Hep G2 cells and human fibroblasts. Int. J. Biochem. Cell Biol. 28, 677-681.
26. Motter R., Vigo-Pelfrey C., Kholodenko D. et al. (1995) Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann. Neurol. 38, 643-648.
27. Rakhit R., Crow J. P., Lepock J. R., Kondejewski L. H., Cashman N. R. and Chakrabartty A. (2004) Monomeric Cu, Zn-superoxide dismutase is a common misfolding intermediate in the oxidation models of sporadic and familial amyotrophic lateral sclerosis. J. Biol. Chem. 279, 15499-15504.
28. Rosen D. R., Siddique T., Patterson D. et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62. (Pubitemid 23087289)
29. Turner B. J., Atkin J. D., Farg M. A., Zang D. W., Rembach A., Lopes E. C., Patch J. D., Hill A. F. and Cheema S. S. (2005) Impaired extracellular secretion of mutant superoxide dismutase 1 associates with neurotoxicity in familial amyotrophic lateral sclerosis. J. Neurosci. 25, 108-117. (Pubitemid 40110771)
30. Urushitani M., Sik A., Sakurai T., Nukina N., Takahashi R. and Julien J. P. (2006) Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat. Neurosci. 9, 108-118.
31. Urushitani M., Ezzi S. A. and Julien J. P. (2007) Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 104, 2495-2500.
32. Watanabe Y., Adachi Y. and Nakashima K. (2001) Japanese familial amyotrophic lateral sclerosis family with a two-base deletion in the superoxide dismutase-1 gene. Neuropathology 21, 61-66. (Pubitemid 32280389)
33. Wroe R., Wai-Ling Butler A., Andersen P. M., Powell J. F. and Al-Chalabi A. (2008) ALSOD: the Amyotrophic Lateral Sclerosis Online Database. Amyotroph. Lateral Scler. 9, 249-250.
34. Wuolikainen A., Hedenstrom M., Moritz T., Marklund S. L., Antti H. and Andersen P. M. (2009) Optimization of procedures for collecting and storing of CSF for studying the metabolome in ALS. Amyotroph. Lateral Scler. 10, 229-236.
35. Zetterstrom P., Stewart H. G., Bergemalm D., Jonsson P. A., Graffmo K. S., Andersen P. M., Brannstrom T., Oliveberg M. and Marklund S. L. (2007) Soluble misfolded subfractions of mutant superoxide dismutase-1s are enriched in spinal cords throughout life in murine ALS models. Proc. Natl Acad. Sci. USA 104, 14157-14162.
36. Zhao W., Beers D. R., Henkel J. S., Zhang W., Urushitani M., Julien J. P. and Appel S. H. (2010) Extracellular mutant SOD1 induces microglial-mediated motoneuron injury. Glia 58, 231-243.